EP3491025
FcRn mótefni og aðferðir til notkunar á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
31.7.2017EP published:
18.10.2023EP application number:
17835436.1
EP translation filed:
18.12.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
30.7.2037Expiry date:
30.7.2026Next due date:
31.7.2026
Title in English:
FCRN ANTIBODIES AND METHODS OF USE THEREOFLanguage of the patent:
English
Timeline
Today
31.7.2017EP application
18.10.2023EP Publication
18.12.2023Translation submitted
15.1.2024Registration published
30.7.2026Expires
Owner
Name:
Momenta Pharmaceuticals, Inc.Address:
1125 Trenton-Harbourton Road, Titusville, NJ 08560, US
Inventor
Name:
LING, Leona, E.Address:
Winchester, MA 01890, US
Name:
ROY, SucharitaAddress:
Tyngsboro, MA 01879, US
Name:
WASHBURN, NathanielAddress:
Littleton, MA 01460, US
Name:
KEHRY, MarilynAddress:
San Diego, CA 92131, US
Name:
KING, David, J.Address:
Encinitas, CA 92024, US
Name:
MEADOR, James, IIIAddress:
Framingham, MA 01702, US
Name:
MANNING, AnthonyAddress:
Cambridge, MA 02139, US
Name:
HILLSON, JanAddress:
Cambridge, MA 02139-1047, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662368770 PDate:
29.7.2016Country:
US
Number:
201662368803 PDate:
29.7.2016Country:
US
Classification
Categories:
C07K 16/28, G01N 33/68, A61P 37/00, A61P 37/02
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 7.6.2024
Expires: 30.7.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 9.7.2025
Expires: 30.7.2026
Payer: Árnason Faktor ehf.